Bausch Health Companies (BHC) EBT (2009 - 2026)
Bausch Health Companies' (BHC) quarterly EBT came in at $348.0 million in Q2 2026, up 148.57% year-over-year from $140.0 million in Q2 2025, and up 125.7% quarter-over-quarter from -$1.4 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) EBT (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed EBT across 18 years of filings, most recently posting $348.0 million for Q2 2026.
- In Q2 2026, EBT rose 148.57% year-over-year to $348.0 million; the TTM figure through Jun 2026 stood at -$732.0 million (down 360.5% YoY), while the FY2025 annual figure was $367.0 million, up 119.76% from the prior year.
- EBT came in at $348.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
- In the past five years, EBT ranged from a high of $439.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
- Average EBT over 5 years is -$55.1 million, with a median of -$14.0 million recorded in 2023.
- Year-over-year, EBT surged 3085.71% in 2024 and slumped 2780.85% in 2026.
- Over 5 years, EBT stood at -$357.0 million in 2022, then soared by 98.04% to -$7.0 million in 2023, then surged by 3085.71% to $209.0 million in 2024, then tumbled by 73.21% to $56.0 million in 2025, then jumped by 521.43% to $348.0 million in 2026.
- Per Business Quant data, the three most recent EBT figures were $348.0 million in Q2 2026, -$1.4 billion in Q1 2026, and $56.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -455.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -64.00 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 58.37 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 70.99 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 348.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -66.76 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 37.10 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 38.54 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 2.02 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 348.00 Mn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | 56.00 Mn |
| Sep 30, 2025 | 218.00 Mn |
| Jun 30, 2025 | 140.00 Mn |
| Mar 31, 2025 | -47.00 Mn |
| Dec 31, 2024 | 209.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | 48.00 Mn |
| Mar 31, 2024 | -69.00 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Sep 30, 2023 | -326.00 Mn |
| Jun 30, 2023 | 79.00 Mn |
| Mar 31, 2023 | -136.00 Mn |
| Dec 31, 2022 | -357.00 Mn |
| Sep 30, 2022 | 439.00 Mn |
| Jun 30, 2022 | -129.00 Mn |
| Mar 31, 2022 | -82.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 216.00 Mn |